These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7903825)

  • 41. [Importance of renin-angiotensin-aldosterone system in diverse forms of hypertension].
    Werning C; Weidmann P; Vetter W; Stiel D; Schweikert HU; Siegenthaler W
    Schweiz Rundsch Med Prax; 1970 May; 59(20):730-7. PubMed ID: 4321141
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
    Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
    [No Abstract]   [Full Text] [Related]  

  • 43. Co-existence of renovascular hypertension, polyarteritis nodosa, antiphospholipid syndrome and methylenetetrahydrofolate reductase mutation.
    Yildiz B; Cetin N; Kural N; Kaya T; Akcar N
    Pediatr Int; 2013 Aug; 55(4):e107-10. PubMed ID: 23910811
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The renin-angiotensin system as a primary cause of polyarteritis nodosa in rats.
    Peters BS; Kuttler B; Beineke A; Lorenz G; Thiele A; Nicolai O; Rettig R; Mullins JJ; Peters J
    J Cell Mol Med; 2010 Jun; 14(6A):1318-27. PubMed ID: 19432815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Abnormal relation between exchangeable sodium and the renin-angiotensin system in malignant hypertension and in hypertension with chronic renal failure.
    Davies DL; Beevers DG; Briggs JD; Medina AM; Robertson JI; Schalekamp MA; Brown JJ; Lever AF; Morton JJ; Tree M
    Lancet; 1973 Mar; 1(7805):683-6. PubMed ID: 4120488
    [No Abstract]   [Full Text] [Related]  

  • 46. [Renin and arterial hypertension].
    Schwartz J; Bloch R; Imbs JL; Fontaine JL; Velly J
    Presse Med (1893); 1969 Feb; 77(7):237-40. PubMed ID: 4307569
    [No Abstract]   [Full Text] [Related]  

  • 47. Fibromuscular dysplasia of the renal artery with medial dissection. A case simulating polyarteritis nodosa.
    Meyers DS; Grim CE; Keitzer WF
    Am J Med; 1974 Mar; 56(3):412-6. PubMed ID: 4149855
    [No Abstract]   [Full Text] [Related]  

  • 48. [Renal hemodynamics, the renin-angiotensin system and prostaglandins in the malignant and stable course of arterial hypertension].
    Kutsenko AI; Shpil'kin VM; Boiadzhan PP; Levitskaia IuV; Shapkina LS
    Kardiologiia; 1980 Apr; 20(4):41-6. PubMed ID: 6990083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Remission of Angiographically Confirmed Minocycline-induced Renal Polyarteritis Nodosa: A Case Report and Literature Review.
    Yokota K; Kurihara I; Nakamura T; Nakatsuka S; Miyashita K; Kobayashi S; Murai-Takeda A; Sone M; Itoh H
    Intern Med; 2022 Jan; 61(1):103-110. PubMed ID: 34176836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polyarteritis nodosa involving only the main renal arteries.
    Hoover LA; Hall-Craggs M; Dagher FJ
    Am J Kidney Dis; 1988 Jan; 11(1):66-9. PubMed ID: 2892393
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma renin activity in healthy subjects and patients with hypertension. Preliminary experience with a rapid and quantitative bio-assay.
    Gunnells JC; Grim CE; Robinson RR; Wildermann NM
    Arch Intern Med; 1967 Mar; 119(3):232-40. PubMed ID: 6019940
    [No Abstract]   [Full Text] [Related]  

  • 52. Renal origin of malignant hypertension.
    Vaisrub S
    JAMA; 1970 Sep; 213(11):1889-90. PubMed ID: 5468918
    [No Abstract]   [Full Text] [Related]  

  • 53. [Role of renin-angiotensin-aldosterone system in pathogenesis of arterial hypertension in chronic renal failure].
    Lifshits NL; Kutyrina IM
    Ter Arkh; 1999; 71(6):64-7. PubMed ID: 10420461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Regression of malignant hypertension and polyneuropathy following combined treatment of severe polyarteritis nodosa].
    Dyk T; Dubaniewicz L
    Wiad Lek; 1978 Oct; 31(19):1387-91. PubMed ID: 31035
    [No Abstract]   [Full Text] [Related]  

  • 55. [Beware, polyarteritis nodosa still exists in nephrology!].
    Perrin J; Carvelli J; Gondouin B; Daniel L; Fraisse M; Gaudon C; Bouzana F; Vacher-Coponat H; Moussi-Francès J; Dussol B; Jourde-Chiche N
    Nephrol Ther; 2016 Nov; 12(6):463-467. PubMed ID: 27686032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The renin-angiotensin-aldosterone system in hypertensive subjects. III- The use of beta-blockers in reno-vascular hypertension (author's transl)].
    Lardoux H; Vial FS; Ménard J; Corvol P; Milliez P
    Nouv Presse Med; 1977 Sep; 6(30):2659-63. PubMed ID: 20602
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent developments in pathophysiologic studies of the renin-angiotensin system.
    Haber E
    N Engl J Med; 1969 Jan; 280(3):148-55. PubMed ID: 4302194
    [No Abstract]   [Full Text] [Related]  

  • 58. Pathogenesis of malignant hypertension: experimental evidence from the renal hypertensive rat.
    Möhring J
    Clin Nephrol; 1975 Nov; 4(5):167-74. PubMed ID: 1192618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL; Henik RA; Stepien RL
    Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Relationship between fibrinogen level, blood pressure and plasma renin activity in hypertensive patients (preliminary reports)].
    Sonkodi S; Rednik A; Kovács A
    Orv Hetil; 1975 Mar; 116(13):732-4. PubMed ID: 1118139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.